Hyun Myung Chul
Department of Pediatrics, Kyungpook National University Hospital, Daegu, Korea.
Korean J Pediatr. 2017 Dec;60(12):390-394. doi: 10.3345/kjp.2017.60.12.390. Epub 2017 Dec 22.
Atrioventricular nodal reentry tachycardia (AVNRT) is less common in pediatric patients than in adult patients. Thus, data for pediatric AVNRT patients are insufficient. Hence, we aimed to analyze the patient characteristics, treatment, and any recurrences in pediatric AVNRT patients.
We reviewed the records of 50 pediatric AVNRT patients who had undergone radiofrequency catheter ablation (RFCA) between January 1998 and December 2016 at a single regional center. The patients were aged ≤18 years.
Among 190 pediatric patients who underwent RFCA for tachyarrhythmia, 50 (26.3%; mean age, 13.4±2.6 years) were diagnosed as having AVNRT by electrophysiological study. Twenty-five patients (25 of 50, 50%) were male. Twenty patients (20 of 50, 40%) used beta-blockers before RFCA. All patients had no structural heart disease except 1 patient with valvular aortic stenosis and coarctation of the aorta. RFCA was performed using the anatomic approach under fluoroscopic guidance. The most common successfully ablated region was the midseptal region (25 of 50, 50%). Slow pathway (SP) ablation and SP modulation were performed in 43 and 6 patients, respectively. Complication occurred in 1 patient with complete atrioventricular block. During follow-up, 6 patients had recurrence of supraventricular tachycardia, as confirmed by electrocardiography. Among them, 5 underwent successful ablation at the first procedure. In 1 patient, induction failed during the first procedure.
RFCA is safe and effective in pediatric AVNRT patients. However, further research is needed for establishing the endpoints of ablation in pediatric AVNRT patients and for identifying risk factors by evaluating data on AVNRT recurrence after RFCA.
房室结折返性心动过速(AVNRT)在儿科患者中比在成人患者中少见。因此,儿科AVNRT患者的数据不足。因此,我们旨在分析儿科AVNRT患者的特征、治疗及任何复发情况。
我们回顾了1998年1月至2016年12月在一个地区中心接受射频导管消融(RFCA)的50例儿科AVNRT患者的记录。患者年龄≤18岁。
在190例因快速心律失常接受RFCA的儿科患者中,50例(26.3%;平均年龄13.4±2.6岁)经电生理研究诊断为AVNRT。25例患者(50例中的25例,50%)为男性。20例患者(50例中的20例,40%)在RFCA前使用β受体阻滞剂。除1例患有主动脉瓣狭窄和主动脉缩窄的患者外,所有患者均无结构性心脏病。RFCA在透视引导下采用解剖方法进行。最常见的成功消融区域是中隔区域(50例中的25例,50%)。分别对43例和6例患者进行了慢径(SP)消融和SP调制。1例患者发生完全性房室传导阻滞并发症。随访期间,6例患者经心电图证实有室上性心动过速复发。其中,5例在首次手术时成功消融。1例患者在首次手术时诱发失败。
RFCA对儿科AVNRT患者安全有效。然而,需要进一步研究以确定儿科AVNRT患者的消融终点,并通过评估RFCA后AVNRT复发的数据来识别危险因素。